Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China · Delayed Price · Currency is CNY 8.70
-0.05 (-0.57%)
Feb 13, 2026, 3:00 PM CST
SHA:600867 Market Cap
SHA:600867 has a market cap or net worth of 16.91 billion as of February 23, 2026. Its market cap has increased by 12.69% in one year.
Market Cap
16.91B
Enterprise Value
16.04B
Revenue
2.74B
Ranking
n/a
PE Ratio
13.87
Stock Price
8.70
Market Cap Chart
Since February 15, 2001, SHA:600867's market cap has increased from 3.86B to 16.91B, an increase of 337.87%. That is a compound annual growth rate of 6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 16.91B | 6.49% |
| Dec 31, 2025 | 15.88B | 1.06% |
| Dec 31, 2024 | 15.71B | -26.86% |
| Dec 29, 2023 | 21.48B | 17.97% |
| Dec 30, 2022 | 18.21B | -17.83% |
| Dec 31, 2021 | 22.16B | -17.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Buchang Pharmaceuticals | 17.80B |
| Shenzhen Kangtai Biological Products | 16.59B |
| Hybio Pharmaceutical | 16.16B |
| Guangdong Zhongsheng Pharmaceutical | 16.11B |
| Shenzhen Hepalink Pharmaceutical Group | 16.08B |
| Wedge Industrial | 15.89B |
| Nanjing King-Friend Biochemical Pharmaceutical | 15.88B |
| Guobang Pharma | 15.79B |